ReviewAAPS PharmSciTech2026
Comprehensive Modalities for Cataract Management: Preventive, Surgical, and Non-Surgical Approaches Using Conventional and Nanotechnology-Based Therapies.
Review in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among ocular diseases, cataract are globally considered the primary cause of blindness. Cataract development is mainly attributed to oxidative stress, which damages epithelial lens proteins and lipids, resulting in clouding or opacification of the normally transparent lens and altering its refractive index. The widespread prevalence of environmental and pathological factors associated with increased cataract risk has heightened interest in innovative therapeutic strategies. Addressing the limitations of current pharmaceutical and surgical interventions is crucial, and the emergence of nanomedicine offers promising opportunities for more precise and effective treatment and prevention strategies compared to conventional methods. Due to their unique properties, nanoparticles have demonstrated significant potential in targeting biological systems and modulating critical physiological processes. This review highlights the potential of various traditional and nanotechnology-based therapeutic agents, including chemical compounds, antioxidants and herbal extracts showing anti-cataract activity both in vitro and in vivo. Furthermore, it explores the benefits and challenges associated with various ocular drug delivery routes for cataract treatment and prevention.
Indexed as
Identifiers
41952015What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.